12-month periodised protocol calendars β every compound phased correctly, blood work windows built in, male and female doses side by side. Select your goal below. Print and pin it up.
π Calendars are always free β no subscription required
A 12-month periodised longevity protocol addressing telomere maintenance, mitochondrial function, immune senescence, and tissue quality. Foundation compounds run year-round; intensive courses are timed to spring and autumn.
β Consult a practitioner before starting
Sensitisation β start low
Titration β find level
Therapeutic β maintain
Taper β reduce
Off β rest period
π¬Blood work required
π Starting month β adjust if beginning mid-year
The protocol sequence stays the same β the calendar months shift to match when you start. Month 1 of the protocol always runs in your chosen start month.
OCTPre-annual: full panel Β· epigenetic clock repeat
π Dose Reference β Male & Female
Compound
β Male Dose
β Female Dose
Cycle Notes
Collagen Peptides
15β20g oral daily
10β15g oral daily
Foundation β never stops
GHK-Cu
Topical 1% daily + 0.5β1mg SubQ 3Γ/wk
Same β no sex difference
Foundation β continuous
NADβΊ / NMN
500β1000mg NMN oral daily
Same dose
3 months on Β· 1 month off
Sermorelin
300mcg SubQ nightly
200mcg SubQ nightly β women more sensitive
Nightly β continuous
Thymosin Ξ±-1
1.5mg SubQ twice weekly
Same dose
12-week courses β spring & autumn
SS-31
2β4mg SubQ 5Γ/week
Same dose
12 weeks on Β· 8 weeks off
MOTS-c
5β10mg SubQ 3β5Γ/week
Same dose
Cycling with SS-31 gaps
Epitalon
5β10mg SubQ daily Γ 10 days
Same dose
10-day courses: Jan & Sep
Literature and community-reported dose ranges. Not a prescription or personal recommendation. Always establish your individual dose with a qualified practitioner. Start at the sensitisation phase minimum β never begin at the therapeutic range.
Protocol Calendar
Anti-Ageing Protocol
Female Β· 40β55 Β· Annual Schedule
A 12-month female-specific longevity protocol with Sermorelin at 30β50% lower dose than men, cycle-aware blood work timing, and GHK-Cu emphasis for the oestrogen-collagen hormonal synergy. Test blood work at days 8β12 of cycle if premenopausal.
β Consult a practitioner before starting
Sensitisation β start low
Titration β find level
Therapeutic β maintain
Taper β reduce
Off β rest period
π¬Blood work required
π Starting month β adjust if beginning mid-year
The protocol sequence stays the same β the calendar months shift to match when you start. Month 1 of the protocol always runs in your chosen start month.
JULMid-year: full panel Β· inflammation markers Β· mammography if due (days 8β12 of cycle)
OCTPre-annual: epigenetic clock repeat Β· bone density if post-menopausal
π Dose Reference β Male & Female
Compound
β Male Dose
β Female Dose
Cycle Notes
Collagen Peptides
15β20g oral daily
10β15g oral daily
Foundation β never stops
GHK-Cu
Topical 1% + SubQ 3Γ/wk
Same β enhanced response in women (oestrogen-collagen synergy)
Foundation β continuous
NADβΊ / NMN
500mg NMN daily
Same dose
3 months on Β· 1 month off
Sermorelin
300mcg SubQ nightly
200mcg SubQ nightly β lower dose, same IGF-1 target
Nightly β women need lower dose
Thymosin Ξ±-1
1.5mg SubQ twice weekly
Same dose
12-week courses β spring & autumn
Epitalon
5β10mg SubQ Γ 10 days
Same dose
10-day courses: Jan & Sep
Kisspeptin-10
N/A β male TRT context
50mcg SubQ 2Γ/week β perimenopausal HPG support
Female-specific Β· 3-month cycles
Literature and community-reported dose ranges. Not a prescription or personal recommendation. Always establish your individual dose with a qualified practitioner. Start at the sensitisation phase minimum β never begin at the therapeutic range.
Protocol Calendar
Injury Recovery Protocol
All Ages Β· Tissue Repair Β· Annual Resilience Plan
Structured around a primary injury recovery period followed by a maintenance and resilience phase. BPC-157 and TB-500 form the recovery foundation; collagen and GHK-Cu maintain connective tissue quality year-round.
β Consult a practitioner before starting
Sensitisation β start low
Titration β find level
Therapeutic β maintain
Taper β reduce
Off β rest period
π¬Blood work required
π Starting month β adjust if beginning mid-year
The protocol sequence stays the same β the calendar months shift to match when you start. Month 1 of the protocol always runs in your chosen start month.
Literature and community-reported dose ranges. Not a prescription or personal recommendation. Always establish your individual dose with a qualified practitioner. Start at the sensitisation phase minimum β never begin at the therapeutic range.
Protocol Calendar
Hormonal Optimisation β TRT
Male Β· Testosterone Replacement Β· Annual Protocol
Male TRT with full HPG axis preservation β testosterone alongside Gonadorelin to maintain pituitary connection and testicular function. Blood work at every quarter, always at trough (48h post-injection).
β Consult a practitioner before starting
Sensitisation β start low
Titration β find level
Therapeutic β maintain
Taper β reduce
Off β rest period
π¬Blood work required
π Starting month β adjust if beginning mid-year
The protocol sequence stays the same β the calendar months shift to match when you start. Month 1 of the protocol always runs in your chosen start month.
JANBaseline trough: total T Β· free T Β· LH + FSH Β· E2 Β· haematocrit Β· PSA (45+)
APRQuarterly trough: total T Β· E2 Β· haematocrit Β· LH (gonadorelin working?)
JULMid-year trough: full panel Β· lipids Β· metabolic Β· PSA
OCTPre-annual trough: full hormonal + safety panel
π Dose Reference β Male & Female
Compound
β Male Dose
β Female Dose
Cycle Notes
Testosterone
80β200mg SubQ weekly β physician prescribed
N/A β see female TRT protocol
Continuous β physician supervised
Gonadorelin
100β200mcg SubQ twice daily
N/A
Twice daily β maintains HPG axis
Kisspeptin-10
50β100mcg SubQ 2β3Γ/week if needed
N/A
Add if LH undetectable on gonadorelin alone
BPC-157
250mcg SubQ daily for injury prevention
N/A
Injury prevention cycles β optional
Literature and community-reported dose ranges. Not a prescription or personal recommendation. Always establish your individual dose with a qualified practitioner. Start at the sensitisation phase minimum β never begin at the therapeutic range.
Protocol Calendar
Endurance Athlete Protocol
Marathon Β· Cycling Β· Triathlon Β· WADA-Aware
Built around the endurance training year β base phase, build, peak, and recovery. Overuse injury management is the primary peptide application. Mitochondrial compounds for efficiency gains. All compounds listed are currently WADA-permitted (verify before competition).
β Consult a practitioner before starting
Sensitisation β start low
Titration β find level
Therapeutic β maintain
Taper β reduce
Off β rest period
π¬Blood work required
π Starting month β adjust if beginning mid-year
The protocol sequence stays the same β the calendar months shift to match when you start. Month 1 of the protocol always runs in your chosen start month.
SEPPost-season: full iron panel Β· HPA axis (cortisol + DHEA-S) Β· recovery markers
DECOff-season: full panel Β· ferritin Β· plan next year supplementation
π Dose Reference β Male & Female
Compound
β Male Dose
β Female Dose
Cycle Notes
BPC-157
250β500mcg SubQ daily Β· injury management
Same dose
WADA: not currently prohibited Β· verify annually
TB-500
2mg SubQ weekly maintenance
Same dose
WADA: not currently prohibited Β· verify annually
Collagen Peptides
15g oral + Vit C daily β 30 min pre-training
10β15g oral daily
Year-round β connective tissue protection
SS-31
2mg SubQ 5Γ/week β peak training blocks
Same dose
WADA: not currently prohibited
MOTS-c
5mg SubQ 3Γ/week β build phase
Same dose
WADA: not currently prohibited Β· verify
NADβΊ / NMN
500mg NMN oral daily
Same dose
Year-round mitochondrial support
Literature and community-reported dose ranges. Not a prescription or personal recommendation. Always establish your individual dose with a qualified practitioner. Start at the sensitisation phase minimum β never begin at the therapeutic range.
A systematic replacement of what the body progressively stops making from age 40. Three sequential layers β Foundation (months 1β3), Hormonal (months 3+, physician required), and Advanced (months 6+). Never start at the advanced layer. Each layer must be established before the next is added.
β Physician supervised Β· blood tests required
Sensitisation β start low
Titration β find level
Therapeutic β maintain
Taper β reduce
Off β rest period
π¬Blood work required
Foundation β Month 1β3
Collagen Β· GHK-Cu Β· NAD+/NMN oral Β· NAD+ IV/IM Β· Sermorelin. Start here and establish before adding anything else. Blood test at month 1 baseline.
Hormonal β Month 3+ Β· Physician Required
Testosterone (if blood test confirms low) Β· Gonadorelin (β) Β· MK-677 Β· Thymosin Ξ±-1. Only add after foundation is established and blood tests confirm the need.
Advanced β Month 6+ Β· After Hormonal Stable
SS-31 Β· MOTS-c Β· Epitalon Β· 5-Amino-1MQ. Only after hormonal layer is fully established and well tolerated. Each added one at a time β assess before layering.
π Starting month β adjust if beginning mid-year
The protocol sequence stays the same β the calendar months shift to match when you start. Month 1 of the protocol always runs in your chosen start month.
Add at month 6 Β· NNMT inhibitor Β· NAD+ companion
Literature and community-reported dose ranges shown. Not a prescription or personal recommendation. Testosterone, Gonadorelin, and MK-677 require physician supervision and blood test confirmation before starting. Always establish your individual dose at the sensitisation phase minimum. The hormonal and advanced layers must only be added after the foundation layer is fully established and well tolerated.